Showing results (181-190 of 658) with videos related to
Sort By:
Pageof 66
Neuro-Oncology|November 2, 2021
Utilizing preclinical models to develop targeted therapies for rare central nervous system cancersAleena K S Arakaki, Frank Szulzewsky, Mark R Gilbert, et al.Neuroepidemiology|August 1, 2012
Predictors of survival among pediatric and adult ependymoma cases: a study using Surveillance, Epidemiology, and End Results data from 1973 to 2007E Susan Amirian, Terri S Armstrong, Kenneth D Aldape, et al.Cancer Medicine|August 5, 2024
Identifying associations between sample characteristics, symptoms, and self-efficacy differences in adult patients with rare tumors of the central nervous system who participated in a novel web-based natural history studyAlvina Acquaye-Mallory, Elizabeth Vera, Anna Choi, et al.Journal of the Neurological Sciences|May 27, 2018
MRI venous architecture of insulaBhanu Gogia, Lakshmi S Chavali, Frederick F Lang, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|February 7, 2008
Delta-24-RGD in combination with RAD001 induces enhanced anti-glioma effect via autophagic cell deathMarta M Alonso, Hong Jiang, Tomohisa Yokoyama, et al.Journal of Neurosurgery|September 13, 2011
Neurocognitive function before and after surgery for insular gliomasAdam S Wu, Mariana E Witgert, Frederick F Lang, et al.Neuropathology : Official Journal of the Japanese Society of Neuropathology|February 28, 2024
Collision tumor: Multinodular and vacuolating neuronal tumor with isocitrate dehydrogenase-mutant diffuse astrocytomaVinodh A Kumar, Alejandro Perez, Angela L Young, et al.Cancer Research|March 16, 2013
Novel HSP90 inhibitor NVP-HSP990 targets cell-cycle regulators to ablate Olig2-positive glioma tumor-initiating cellsJun Fu, Dimpy Koul, Jun Yao, et al.Cancer Research|November 19, 2009
Human bone marrow-derived mesenchymal stem cells for intravascular delivery of oncolytic adenovirus Delta24-RGD to human gliomasRaymund L Yong, Naoki Shinojima, Juan Fueyo, et al.Journal of Proteome Research|February 3, 2007
Proteomic investigation of glioblastoma cell lines treated with wild-type p53 and cytotoxic chemotherapy demonstrates an association between galectin-1 and p53 expressionMaja Puchades, Carol L Nilsson, Mark R Emmett, et al.Pageof 66